169
Views
21
CrossRef citations to date
0
Altmetric
Perspective

Keeping it in the family: the case for considering late-onset combined immunodeficiency a subset of common variable immunodeficiency disorders

, , , , &
Pages 549-556 | Received 05 Apr 2018, Accepted 24 May 2018, Published online: 26 Jun 2018

References

  • Abbott JK, Gelfand EW. Common variable immunodeficiency: diagnosis, management, and treatment. Immunol Allergy Clin North Am. 2015;35(4):637–658.
  • Ameratunga R, Lehnert K, Woon ST, et al. Review: diagnosing common variable immunodeficiency disorder in the era of genome sequencing. Clin Rev Allergy Immunol. 2017.
  • Maffucci P, Filion CA, Boisson B, et al. Genetic diagnosis using whole exome sequencing in common variable immunodeficiency. Front Immunol. 2016;7:220.
  • Mohammadinejad P, Aghamohammadi A, Abolhassani H, et al. Pediatric patients with common variable immunodeficiency: long-term follow-up. J Invest Allergology Clin Immunol. 2012;22(3):208–214.
  • Ameratunga R, Woon ST, Gillis D, et al. New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin. Clin Exp Immunol. 2013;174(2):203–211.
  • Chapel H, Lucas M, Lee M, et al. Common variable immunodeficiency disorders: division into distinct clinical phenotypes. Blood. 2008;112(2):277–286.
  • Ameratunga R, Becroft DM, Hunter W. The simultaneous presentation of sarcoidosis and common variable immune deficiency. Pathology. 2000;32(4):280–282.
  • Duarte AJ, Vasconcelos DM, Sato MN, et al. [Common variable immunodeficiency (hypogammaglobulinemia of late onset or acquired hypogammaglobulinemia): initial follow-up of 11 cases]. Rev Hosp Clin Fac Med Sao Paulo. 1990;45(3):95–104.
  • Malphettes M, Gerard L, Carmagnat M, et al. Late-onset combined immune deficiency: a subset of common variable immunodeficiency with severe T cell defect. Clin Infect Dis. 2009;49(9):1329–1338.
  • Papakonstantinou I, Baraboutis IG, Karnesis L. Late onset combined immunodeficiency presenting with recurrent Pneumocystis jiroveci pneumonia. Case Rep Med. 2014;2014:1–7.
  • Ameratunga R, Brewerton M, Slade C, et al. Comparison of diagnostic criteria for common variable immunodeficiency disorder. Front Immunol. 2014;5:415.
  • Bonilla FA, Barlan I, Chapel H, et al. International Consensus Document (ICON): common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(1):38–59.
  • Bertinchamp R, Gerard L, Boutboul D, et al. Exclusion of patients with a severe T-cell defect improves the definition of common variable immunodeficiency. J Allergy Clin Immunol Pract. 2016;4(6):1147–1157.
  • Buchbinder D, Baker R, Lee YN, et al. Identification of patients with RAG mutations previously diagnosed with common variable immunodeficiency disorders. J Clin Immunol. 2015;35(2):119–124.
  • Sundin M, Uhlin M, Gaballa A, et al. Late presenting atypical severe combined immunodeficiency (SCID) associated with a novel missense mutation in DCLRE1C. Pediatr Allergy Immunol. 2018 Feb;29(1):108–111.
  • Kobbe R, Kolster M, Fuchs S, et al. Common variable immunodeficiency, impaired neurological development and reduced numbers of T regulatory cells in a 10-year-old boy with a STAT1 gain-of-function mutation. Gene. 2016;586(2):234–238.
  • Abolhassani H, Wang N, Aghamohammadi A, et al. A hypomorphic recombination-activating gene 1 (RAG1) mutation resulting in a phenotype resembling common variable immunodeficiency. J Allergy Clin Immunol. 2014;134(6):1375–1380.
  • Abolhassani H, Cheraghi T, Rezaei N, et al. Common variable immunodeficiency or Late-onset combined immunodeficiency: a new hypomorphic JAK3 patient and review of the literature. J Invest Allergology Clin Immunol. 2015;25(3):218–220.
  • Geier CB, Piller A, Linder A, et al. Leaky RAG deficiency in adult patients with impaired antibody production against bacterial polysaccharide antigens. PLoS One. 2015;10(7):e0133220.
  • Abolhassani H, Chou J, Bainter W, et al. Clinical, immunologic, and genetic spectrum of 696 patients with combined immunodeficiency. J Allergy Clin Immunol. 2018;141(4):1450–1458.
  • Hsu AP, Pittaluga S, Martinez B, et al. IL2RG reversion event in a common lymphoid progenitor leads to delayed diagnosis and milder phenotype. J Clin Immunol. 2015;35(5):449–453.
  • Schepp J, Chou J, Skrabl-Baumgartner A, et al. 14 years after discovery: clinical follow-up on 15 patients with inducible co-stimulator deficiency. Front Immunol. 2017;8:964.
  • Fliegauf M, Bryant LV, Frede N, et al. Haploinsufficiency of the NF-κB1 Subunit p50 in common variable immunodeficiency. Am J Hum Genet. 2015;97(3):389–403.
  • Ameratunga R, Lederman HM, Sullivan KE, et al. Defective antigen-induced lymphocyte proliferation in the X-linked hyper-IgM syndrome. J Pediatr. 1997;131(1 Pt 1):147–150.
  • Orange JS, Ballow M, Stiehm ER, et al. Use and interpretation of diagnostic vaccination in primary immunodeficiency: a working group report of the Basic and Clinical Immunology Interest Section of the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2012;130(3 Suppl):S1–S24.
  • Empson M, Sinclair J, O’Donnell J, et al. The assessment and management of primary antibody deficiency. N Z Med J. 2004;117(1195):U914.
  • Agarwal S, Cunningham-Rundles C. Treatment of hypogammaglobulinemia in adults: A scoring system to guide decisions on immunoglobulin replacement. J Allergy Clin Immunol. 2013;131(6):1699–1701.
  • Ameratunga R, Koopmans W, Woon ST, et al. Epistatic interactions between mutations of TACI (TNFRSF13B) and TCF3 result in a severe primary immunodeficiency disorder and systemic lupus erythematosus. Clin & Transl Immunol. 2017;6(10):e159.
  • Ameratunga R, Woon ST, Bryant VL, et al. Clinical Implications of digenic inheritiance and epistasis in primary immunodeficiency disorders. Front Immunol. 2018;8:In Press.
  • Azizi G, Rezaei N, Kiaee F, et al. T-cell abnormalities in common variable immunodeficiency. J Invest Allergology Clin Immunol. 2016;26(4):233–243.
  • Giovannetti A, Pierdominici M, Mazzetta F, et al. Unravelling the complexity of T cell abnormalities in common variable immunodeficiency. J Immunol (Baltimore, Md: 1950). 2007;178(6):3932–3943.
  • Wong GK, Huissoon AP. T-cell abnormalities in common variable immunodeficiency: the hidden defect. J Clin Pathol. 2016;69(8):672–676.
  • Ameratunga RV. Resolution of extensive vulvovaginal condylomatosis following immunoglobulin replacement in primary immunodeficiency disorders. J Allergy Clin Immunol Pract. 2018 May-Jun;6(3):1053–1055.
  • Tesi B, Priftakis P, Lindgren F, et al. Successful hematopoietic stem cell transplantation in a patient with LPS-Responsive Beige-Like Anchor (LRBA) gene mutation. J Clin Immunol. 2016;36(5):480–489.
  • Kuehn HS, Niemela JE, Sreedhara K, et al. Novel nonsense gain-of-function NFKB2 mutations associated with a combined immunodeficiency phenotype. Blood. 2017;130(13):1553–1564.
  • Robertson N, Engelhardt KR, Morgan NV, et al. Astute Clinician Report: A novel 10 bp frameshift deletion in Exon 2 of ICOS causes a combined immunodeficiency associated with an enteritis and hepatitis. J Clin Immunol. 2015;35(7):598–603.
  • Slatter MA, Engelhardt KR, Burroughs LM, et al. Hematopoietic stem cell transplantation for CTLA4 deficiency. J Allergy Clin Immunol. 2016;138(2):615–9.e1.
  • Kaustio M, Haapaniemi E, Goos H, et al. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes. J Allergy Clin Immunol. 2017;140(3):782–796.
  • Elgizouli M, Lowe DM, Speckmann C, et al. Activating PI3Kdelta mutations in a cohort of 669 patients with primary immunodeficiency. Clin Exp Immunol. 2016;183(2):221–229.
  • Tuijnenburg P, Lango Allen H, Burns SO, et al. Loss-of-function nuclear factor κB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans. J Allergy Clin Immunol. 2018 Mar 2. pii: S0091-6749(18)30286-0. doi:10.1016/j.jaci.2018.01.039. [Epub ahead of print]
  • Seppanen M, Aghamohammadi A, Rezaei N. Is there a need to redefine the diagnostic criteria for common variable immunodeficiency? Expert Rev Clin Immunol. 2014 Jan;10(1):1–5.
  • Selenius JS, Martelius T, Pikkarainen S, et al. Unexpectedly high prevalence of common variable immunodeficiency in Finland. Front Immunol. 2017;8:1190.
  • Ameratunga R, Gillis D, Steele R. Diagnostic criteria for common variable immunodeficiency disorders. J Allergy Clin Immunol Pract. 2016;4(5):1017–1018.
  • Ameratunga R, Woon ST, Gillis D, et al. New diagnostic criteria for CVID. Expert Rev Clin Immunol. 2014;10(2):183–186.
  • Hoeger B, Serwas NK, Boztug K. Human NF-kappaB1 haploinsufficiency and Epstein-Barr virus-induced disease-molecular mechanisms and consequences. Front Immunol. 2017;8:1978.
  • Rodriguez-Cortez VC, Del Pino-Molina L, Rodriguez-Ubreva J, et al. Monozygotic twins discordant for common variable immunodeficiency reveal impaired DNA demethylation during naive-to-memory B-cell transition. Nat Commun. 2015;6:7335.
  • Rae W. Indications to epigenetic dysfunction in the pathogenesis of common variable immunodeficiency. Arch Immunol Ther Exp (Warsz). 2017;65(2):101–110.
  • Azizi G, Abolhassani H, Habibi S, et al. Two faces of LRBA deficiency in siblings: hypogammaglobulinemia and normal immunoglobulin levels. J Invest Allergology Clin Immunol. 2018;28(1):48–50.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.